These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

437 related articles for article (PubMed ID: 34595175)

  • 1. Immunopathology and Immunosenescence, the Immunological Key Words of Severe COVID-19. Is There a Role for Stem Cell Transplantation?
    Ligotti ME; Pojero F; Accardi G; Aiello A; Caruso C; Duro G; Candore G
    Front Cell Dev Biol; 2021; 9():725606. PubMed ID: 34595175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remodeling of the Immune Response With Aging: Immunosenescence and Its Potential Impact on COVID-19 Immune Response.
    Cunha LL; Perazzio SF; Azzi J; Cravedi P; Riella LV
    Front Immunol; 2020; 11():1748. PubMed ID: 32849623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Do inflammaging and coagul-aging play a role as conditions contributing to the co-occurrence of the severe hyper-inflammatory state and deadly coagulopathy during COVID-19 in older people?
    Xu K; Wei Y; Giunta S; Zhou M; Xia S
    Exp Gerontol; 2021 Aug; 151():111423. PubMed ID: 34048906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Atluri S; Manchikanti L; Hirsch JA
    Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perspectives on mesenchymal stem/progenitor cells and their derivates as potential therapies for lung damage caused by COVID-19.
    Klimczak A
    World J Stem Cells; 2020 Sep; 12(9):1013-1022. PubMed ID: 33033561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expediting Molecular Translational Approach of Mesenchymal Stem Cells in COVID-19 Treatment.
    Balaji Easwaran V; Satarker S; V Gujaran T; John J; Veedu AP; George KT; Purayil DK; Beegum F; Mathew A; Vibhavari R; Chaudhari SS; Pai KSR
    Curr Stem Cell Res Ther; 2023; 18(5):653-675. PubMed ID: 36424799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 immunopathology with emphasis on Th17 response and cell-based immunomodulation therapy: Potential targets and challenges.
    Pourgholaminejad A; Pahlavanneshan S; Basiri M
    Scand J Immunol; 2022 Feb; 95(2):e13131. PubMed ID: 34936112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stem cell-based therapy and exosomes in COVID-19: current trends and prospects.
    Abdelgawad M; Bakry NS; Farghali AA; Abdel-Latif A; Lotfy A
    Stem Cell Res Ther; 2021 Aug; 12(1):469. PubMed ID: 34419143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies.
    Kaffash Farkhad N; Reihani H; Sedaghat A; Moghadam AA; Moghadam AB; Tavakol-Afshari J
    Regen Ther; 2021 Dec; 18():152-160. PubMed ID: 34124322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aging, inflammaging and immunosenescence as risk factors of severe COVID-19.
    Tizazu AM; Mengist HM; Demeke G
    Immun Ageing; 2022 Nov; 19(1):53. PubMed ID: 36369012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the Immunomodulatory Aspect of Mesenchymal Stem Cells for Treatment of Severe Coronavirus Disease 19.
    Chaudhary JK; Saini D; Chaudhary PK; Maurya A; Verma GK; Gupta AK; Roshan R; Vats TK; Garg N; Yadav D; Kant N; Meena AK; Mirza-Shariff AA
    Cells; 2022 Jul; 11(14):. PubMed ID: 35883618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosenescence, Inflammaging and Resilience: An Evolutionary Perspective of Adaptation in the Light of COVID-19 Pandemic.
    Banić M; Pleško S; Urek M; Babić Ž; Kardum D
    Psychiatr Danub; 2021; 33(Suppl 4):427-431. PubMed ID: 34718260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Immunomodulatory Role of Cell-Free Approaches in SARS-CoV-2-Induced Cytokine Storm-A Powerful Therapeutic Tool for COVID-19 Patients.
    Csobonyeiova M; Smolinska V; Harsanyi S; Ivantysyn M; Klein M
    Biomedicines; 2023 Jun; 11(6):. PubMed ID: 37371831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review and meta-analysis of mesenchymal stromal/stem cells as strategical means for the treatment of COVID-19.
    Taufiq H; Shaik Fakiruddin K; Muzaffar U; Lim MN; Rusli S; Kamaluddin NR; Esa E; Abdullah S
    Ther Adv Respir Dis; 2023; 17():17534666231158276. PubMed ID: 37128999
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 disease treatment: pivotal challenges in the arena of umbilical cord-mesenchymal stem cells (UC-MSCs).
    Soliman AH; Abdellatif M
    Front Cell Dev Biol; 2023; 11():1146835. PubMed ID: 37274737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potency of Mesenchymal Stem Cell and Its Secretome in Treating COVID-19.
    Chouw A; Milanda T; Sartika CR; Kirana MN; Halim D; Faried A
    Regen Eng Transl Med; 2022; 8(1):43-54. PubMed ID: 33723519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The possible pathophysiology mechanism of cytokine storm in elderly adults with COVID-19 infection: the contribution of "inflame-aging".
    Meftahi GH; Jangravi Z; Sahraei H; Bahari Z
    Inflamm Res; 2020 Sep; 69(9):825-839. PubMed ID: 32529477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.
    Kadambari S; Klenerman P; Pollard AJ
    Rev Med Virol; 2020 Sep; 30(5):e2144. PubMed ID: 32671966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of Cytokines and Chemokines in Severe Acute Respiratory Syndrome Coronavirus 2 Infections.
    Hsu RJ; Yu WC; Peng GR; Ye CH; Hu S; Chong PCT; Yap KY; Lee JYC; Lin WC; Yu SH
    Front Immunol; 2022; 13():832394. PubMed ID: 35464491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pulmonary Mesenchymal Stem Cells in Mild Cases of COVID-19 Are Dedicated to Proliferation; In Severe Cases, They Control Inflammation, Make Cell Dispersion, and Tissue Regeneration.
    Henriques-Pons A; Beghini DG; Silva VDS; Iwao Horita S; da Silva FAB
    Front Immunol; 2021; 12():780900. PubMed ID: 35095855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.